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Botulinum toxin (BT), obtained from the bacterium Clostridium botulinum, has 
wide applicability not only in the area of Plastic Surgery to avoid aging, but also in the 
area of reconstruction. 
It has undergone tremendous evolution in the last decade, starting as a poison 
and evolving into a versatile clinical agent with various uses / indications for minimally 
invasive therapeutic purposes. 
It became famous because of its ability to produce deadly neurotoxins. Its 
versatility has made this bacterium one of the best-known bacterial pathogens in the 
history of medicine. Botulinum neurotoxin (BTX) was first used for therapeutic purposes, 
then as a biological weapon, and finally for cosmetic use. 
Although the effect of BT is minimally safe and temporary and its indications are 
evolving from day to day, greater knowledge about the related anatomy is needed as 
well as local and systemic adverse effects. 
Therefore, it was intended with the present study to describe the state of the art 
of the use of botulinum toxin in dental medicine. 
A bibliographic search was performed in PubMed, Scielo and Google Academic 
databases. In turn, the keywords used were the following “Botulinum Toxin”, “Toxina 
Botulínica”, “Odontologia”, “Dental Medicine”, “Dentistry”, “Clostridium botulinum” 
and “botox”.  
It is increasingly used in several areas of medicine, such as Dermatology, 
Ophthalmology, Neurology and, fundamental for this article, Dental Medicine. In this 
last area, there are several functions, both at the level of aesthetics (facial wrinkles, 
gingival smile and asymmetries), such as hypertrophy and hyperactivity of the 
masticatory muscles, pain relief, temporomandibular dysfunction (TMD), parafunctional 
habits, sialorrhoea and functional recovery of surgery dental, oral and maxillofacial. 
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“Botulinum Toxin”, “Toxina Botulínica”, “Odontologia”, “Dental Medicine”, “Dentistry”, 
“Clostridium botulinum”, “botox”.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Toxina Botulínica e as suas diferentes aplicações em Medicina Dentária 
5 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Toxina Botulínica e as suas diferentes aplicações em Medicina Dentária 
6 
 
 
Botulinum neurotoxin (BTX) was first considered as a poison. It was found, 
initially, in the rotten sausage, leading, in this way, to food poisoning. The very word 
botulism derived from the Latin botulus, which means black sausage, and has been 
known to cause food poisoning when eating rotten meat.(1-6) 
Botulism is produced by botulinum toxin (BT) or botulinum neurotoxin (BTX), 
under anaerobic conditions, by Clostridium Botulinum (Gram-positive anaerobic rod-
shaped bacteria present in contaminated food, causing several deaths in Europe to poor 
hygienic conditions in the preparation of food during the Napoleonic War.(1-13) 
It was Justinus Kerner, in 1817, who described "botulism" for the first time as a 
fatal disease and calling it "sausage poisoning," for these were the cause of intoxication. 
In 1822 with the study and publication of the first monograph on this subject Kerner 
came to crucial points and to some conclusions. Among them was that the toxin 
developed in the sausages, growing in anaerobic environment; interrupted the 
neurotransmitter in the Peripheral and Autonomic Nervous System and was lethal in 
small doses.(13-15) 
In addition, this German physicist was able to report some of the neurological 
symptoms of this toxin: vomiting, intestinal spasms, ptosis, dysphagia, respiratory 
failure and mydriasis (pupil dilation).(14) 
However, Kerner also realized the possibility of using it for therapeutic purposes, 
such as in the reduction of the activity of the Sympathetic Nervous System when it is 
associated with movement disorders, hypersecretion of body fluids, ulcers caused by 
malignant diseases, delusions and anger. After several attempts to artificially produce 
this toxin, he concluded that it had biological and animal origin. (13-15) 
Over time it has been described as a very useful tool for minimally invasive 
therapeutic purposes and was the first toxin to be accepted and adopted in medicine in 
1973 with the approval of the US Food and Drug Administration (FDA) in the treatment 
of adult strabismus and blepharospasm in 1989. (1, 11, 16, 17) 
It was Burgen's discovery in 1949, about the role of this toxin in the inhibition of 
presynaptic acetylcholine, that laid the foundation for the clinical application of BT.(12, 
15) 
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It was used for the first time in 1968 in ophthalmology, in the treatment of 
strabismus (blocking the neurotransmitter involved in muscle activity causing this 
problem) by Alan Scott and Edward Schantz.(2, 4, 13, 14, 17, 18) 
The introduction of botulinum toxin in the field of Ophthalmology led to a series 
of investigations in Neurology that allowed the use of this toxin to treat spasmodic 
torticollis, dystonia, spasticity, tremor, vocal disorders, cerebral palsy in children, 
gastrointestinal disorders, tension, headache and pain syndromes. (14) 
Subsequently, in 1987, ophthalmologist Jean Carruthers observed that type A 
botulinum toxin reduced the appearance of wrinkles in the glabellar region when 
treating a patient with blepharospasm and were the first to discover that this toxin was 
effective in relaxing muscles which control the facial expressions, such as the horizontal 
wrinkles around the eyes and nasolabial folds. (12) 
After this discovery, Carruthers shared her observations with her husband 
dermatologist, leading to the promotion of this new substance as a cosmetic product, 
starting in 1990. (14) 
Since then, BT's application has extended its range to several areas of Medicine, 
such as Dermatology, Ophthalmology, Neurology and, fundamental for this review, 
Dental Medicine. In this last area has several functions in terms of aesthetics (facial 
wrinkles, gingival smile and asymmetries), as well as hypertrophy and hyperactivity of 
masticatory muscles, pain relief, temporomandibular joint disorder (TMD), 
parafunctional habits , sialorrhoea and functional recovery of dental, oral and 
maxillofacial surgery. (7, 12) 
Botulinum toxin can be differentiated into seven types from A to G, however 
commercially, BT has two presentations, types A (BTA) and type B (BTB). (1, 2, 4-6, 10) 
The objective of the present study was to investigate, through the literature 
review, the use of this toxin in Dental Medicine, as well as to study its composition and 
to know its use throughout history. 
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A search was performed through Pubmed, Scielo and Google Scholar databases. 
In the PubMed database, using the keywords "botulinum toxin AND dental medicine", 
using the filters "Full text", "5 years" and "humans", 25 articles were found, being used 
7. 
In the database Scielo, using the keyword "botulinum toxin" found 268 articles, 
of which 10 were used. With the keyword "clostridium botulinum", in the same 
database, 52 articles were found and used 5. With the keyword "botox" 21 articles were 
found and used 6. No filters were used in this database.  
In the Google Academic database, using the keyword "clostridium botulinum" 
14400 results were found but only 3 were used. With the keywords “toxina botulínica e 
odontologia” 776 results were found, using only 4 articles. With the words "botulinum 
toxin AND gummy smile" was found 673 results, using 4. With the keyword "masseteric 
hypertrophy AND botox" 1100 results were found, being used 7. No filters were found 
matching any of these keywords. With the keywords "gummy smile AND botox", 18 
results were found, being used 4. The “2014 year” was used as a filter. With the 
keywords "myofascial pain AND botox", 73 results were found, being used 4. As a filter 
was used "since 2018”. With the keywords "atypical odontalgia AND botulinum toxin", 
144 results were found, being used 2. No filters were used. With the keywords 
"parafunctional Habits AND Implants AND botulinum toxin" were found 220 results, 
being used 8. No filters were used.  
Only those articles were used, since after reading the abstract, it did not fit the 
theme, and most of them did not have access to the article. 
Review articles, case reports, clinical trials and studies were selected. 
 
 
 
 
 
 
 
 
Toxina Botulínica e as suas diferentes aplicações em Medicina Dentária 
10 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
 
Toxina Botulínica e as suas diferentes aplicações em Medicina Dentária 
11 
 
Table I. Method used in the selection of articles through electronic research in the PubMed database. 
Keywords Nº of 
Articles 
Nº of 
Selected 
Articles 
Y
e
ar 
 Type of 
Study 
Selected Articles Included Excluded 
 
“botulinum toxin 
AND dental 
medicine” 
25 7 2
0
1
6 
Review  “Clinical Aspects of the Use of Botulinum Toxin Type 
A in the Treatment of Dysfunction of the Masticatory 
System” 
 
X 
 
 
2
0
1
7 
Review “Effectiveness, Safety, and Predictors of Response to 
Botulinum Toxin Type A in Refractory Masticatory 
Myalgia: A Retrospective Study” 
 
X 
 
 
2
0
1
6 
Case 
Report  
“Botulinum Toxin Type A as Preoperative Treatment 
for Immediately Loaded Dental Implants Placed in 
Fresh Extraction Sockets for Full-Arch Restoration of 
Patients With Bruxism” 
 
X 
 
2
0
1
5 
Review “Applications of botulinum toxin in dentistry: A 
comprehensive review” 
 
X 
 
2
0
1
6 
Review “Toxin yet not toxic: Botulinum toxin in dentistry”  
X 
 
2
0
Review “Use of a botulinum toxin A in dentistry and oral and 
maxillofacial surgery” 
 
X 
 
Toxina Botulínica e as suas diferentes aplicações em Medicina Dentária 
12 
 
1
6 
2
0
1
6 
Case 
Report 
“Botulinum Neurotoxin Type-A for the Treatment of 
Atypical Odontalgia” 
 
X 
 
 
Table II. Method used in the selection of articles through electronic research in the Scielo database.  
Keywords Nº of 
Articles 
Nº of 
Selecte
d 
Articles 
Y
e
a
r 
Type of 
Study 
Selected Articles Include
d 
Exclued 
 
“botulinum toxin” 
 
 
 
 
 
268 10 2
0
1
7 
Case 
Report 
“Botulinum toxin as an adjuvant in the treatment 
of gummy smile” 
 
X 
 
2
0
1
7 
Case 
Report 
“Use of botulinum toxin type a in 
temporomandiular disorder” 
 
X 
 
2
0
1
4 
Review  “Botulinum toxin-how a poison turned to a 
fascinating ally against an old adversary” 
 
X 
 
1
9
Review “Treatment of dystonias with botulinum toxin 
Type A” 
 
X 
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9
5 
2
0
0
5 
Clinical 
Trial 
“Application of botulinum toxin to reduce the 
saliva in patients with amyotrophic lateral 
sclerosis” 
 
X 
 
1
9
9
5 
Clinical 
Trial 
“Botulinum toxin in blepharospasm, hemifacial 
spasm and cervical dystonia: results in 33 
patients” 
 
X 
 
1
9
9
6 
Review  “Dystonias: therapeutic aspects”  
X 
 
2
0
0
3 
Case 
Report  
“Bilateral hemifacial spasm: Case report”  
X 
 
2
0
1
1 
Review  “Presentation: Botulinum toxin in the low third of 
the face” 
 
X 
 
“clostridium 
botulinum” 
52 5 2
0
0
9 
Review  “Botulinum Toxin in Pain Treatment”  
X 
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2
0
0
7 
Case 
Report  
“Botulism and dysphagia”  
X 
 
2
0
0
3 
Review  “The History of Clostridium botulinum”  
X 
 
2
0
0
6 
Study  “Botulinum toxin type A in the management of 
Myofascial pain syndrome” 
 
X 
 
2
0
0
4 
Review “Botulinum toxin and its use in oral and 
maxillofacial pathology” 
 
X 
 
“botox” 21 6 2
0
0
3 
Study  “Treatment of essential blepharospasm and 
related facial dystonia with botulinum toxin 
injection - study of 16 cases” 
 
X 
 
2
0
0
4 
Review “Botox. It is not about wrinkles”  
X 
 
 
2
0
Study “Botulinum toxin type A for the management of 
pain in patients with chronic myofascial pain” 
 
X 
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1
0 
2
0
1
5 
Case 
Report 
“Smile enhancement with botulinum toxin in a 
patient with facial palsy” 
 
X 
 
2
0
0
7 
Review  “Salivary gland application of botulinum toxin for 
the treatment of sialorrhea” 
 
X 
 
 
 
1
9
9
7 
Clinical 
Trial  
“Botulinum toxin A: experience in the treatment 
of 115 patients” 
 
X 
 
 
 
Table III: Method used in the selection of articles through electronic research in the Google Académico database. 
Keywords Nº of 
Articles 
Nº of 
Selected 
Articles 
Year Type of 
Study 
Selected Articles Included Exclued 
“clostridium 
botulinum” 
14400 3 2005 Review “Clostridium botulinum: A Bug with Beauty and Weapon”  
X 
 
1982 Review “Clostridium botulinum Toxins”  
X 
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1980 Review “Clostridium botulinum Neurotoxin”  
X 
 
“toxina botulínica e 
odontologia” 
776 4 2015 Review “Applications of botulinum 
toxin in dentistry” 
 
X 
 
2018 Review “Uso Da Toxina Botulínica Como Meio Terapêutico Para 
Tratamento De Assimetria Facial Causada Por Hipertrofia 
Do Músculo Masseter” 
 
X 
 
2013 Review “Uso da toxina botulínica tipo A em pacientes  
com bruxismo reabilitados com prótese 
do tipo protocolo em carga imediata” 
 
X 
 
2014 Case Report “Application of botulinum toxin associated to the 
integrated clinic in the management of gummy smile” 
 
X 
 
 
 
 
“botulinum toxin AND 
gummy smile” 
673 4 2009 Study “Surface Anatomy of the Lip Elevator Muscles for the 
Treatment of Gummy Smile Using Botulinum Toxin” 
 
X 
 
2012 Clinical Trial “A Simplified Method for Smile Enhancement: Botulinum 
Toxin Injection for Gummy Smile” 
 
X 
 
2011 Review “The use of botulinum toxin type 
A in cosmetic facial procedures” 
 
X 
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2012 Review “Current Strategies in the Treatment of Gummy Smile 
Using Botulinum Toxin Type A” 
 
X 
 
“masseteric 
hypertrophy AND 
botox” 
1100 7 2018 Study “Effect of the masseter muscle injection of botulinum 
toxin A on the mandibular bone growth of developmental 
rats” 
 
X 
 
2015 Study “Growth effects of botulinum toxin type A injected 
unilaterally into the masséter muscle of developing rats” 
 
X 
 
2015 Study “Early effect of Botox-A injection into the masséter 
muscle of rats: functional and histological evaluation” 
 
X 
 
2012 Study “Botulinum toxin in masticatory muscles: short- and long-
term effects on muscle, bone, and craniofacial function 
in adult rabbits” 
 
X 
 
2018 Review “Botulinum Toxin in Aesthetic Medicine: Myths and 
Realities” 
 
X 
 
2018 Case Report “A successful management of sever gummy smile using 
gingivectomy and botulinum toxin injection: A case 
report” 
 
X 
 
2018 Case Report “Tratamento De Assimetria Facial Causada Por 
Hipertrofia Do Músculo Masseter Com o Uso De Toxina 
Botulínica Tipo A Relato De Caso Clínico” 
 
X 
 
“gummy smile AND 
botox” 
18 4 2018 Review “O Uso De Toxina Botulínica Como Alternativa Para O 
Tratamento Do Sorriso Gengival Causado Pela 
Hiperatividade Do Lábio Superior” 
 
 
X 
 
2018 Case Report “Adult gummy smile correction with temporary skeletal 
anchorage devices” 
 
 
X 
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2018 Case Report “Myomodulation with Injectable Fillers: An Innovative 
Approach to Addressing Facial Muscle Movement” 
 
 
X 
 
2018 Case Report “Treatment of gingival smile with botulinum toxin type A: 
A case report” 
 
X 
 
“sialorrhea AND botox” 313 3 2018 Review “Surgical Management of the Drooling Child”  
X 
 
2018 Review “Botulinum Toxin A for Sialorrhoea Associated with 
Neurological Disorders: Evaluation of the Relationship 
between Effect of Treatment and the Number of Glands 
Treated” 
 
X 
 
2015 Study “A Double-Blind Randomized Controlled Trial 
Investigating the Most Efficacious Dose of Botulinum 
Toxin-A for Sialorrhea Treatment in Asian Adults with 
Neurological Diseases” 
 
X 
 
“myofascial pain AND 
botox” 
73 4 2018 Review “Botulinum Toxin Injections for Chronic Pain”  
X 
 
2018 Review “A critical overview of the current myofascial pain 
literature” 
 
X 
 
2018 Study “The effectiveness of 
Clostridium botulinum 
toxin A (Dysportâ,AbobotulinumtoxinA) in the 
management of temporomandibular 
dysfunction (TMD) and a small number of other 
maxillofacial 
conditions; an open cohort study” 
 
X 
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2018 Review “Mandibular bone loss: a hidden side effect of botulinum 
toxin type A injection in masticatory muscles” 
 
X 
 
“atypical odontalgia 
AND botulinum toxin” 
144 2 2007 Review “Temporomandibular Disorders and  
Other Causes of Facial Pain” 
 
X 
 
2017 Review “Atypical Facial Pain: a Comprehensive, Evidence-Based 
Review” 
 
X 
 
“parafunctional Habits 
AND Implants AND 
botulinum toxin” 
220 8 2001 Review “A bibliographical survey of bruxism with special 
emphasis on  
non-traditional treatment modalities” 
 
X 
 
2003 Review “Current knowledge on awake and sleep bruxism: 
overview” 
 
X 
 
2013 Review “Role of Botox in Efficient Muscle Relaxation and 
Treatment Outcome: An Overview” 
 
X 
 
2016 Review “Toxina Botulínica Tipo A para bruxismo: análise 
sistemática” 
 
X 
 
2006 Review “Bruxism: its multiple causes and its effects on dental 
implants – an updated review” 
 
X 
 
2006 Review “Dental implants in patients with bruxing habits”  
X 
 
2011 Review “Bruxism: Overview of Current Knowledge and 
Suggestions for Dental Implants Planning” 
 
 
X 
 
2014 Review “Botulinum toxin: The Midas touch”  
X 
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Botulinum toxin as a material 
 
Botulinum toxin (BT) is produced by fermentation of Clostridium botulinum, a 
Gram-positive, anaerobic bacterium. There are seven variants of this neurotoxin, from 
type A to G, type A (BTA) being most often used for therapeutic purposes.(5, 6, 8-10, 13, 19, 
20) 
Commercially, BTX comes in two presentations, types A and B. BTA is the most 
potent variant and the only one clinically used because it is a biological agent obtained 
in the laboratory. It is a stable crystalline substance, lyophilized in human albumin and 
stored in a vacuum, to be diluted in saline. It’s better known by is trade name "Botox" 
(Allergan, Inc, USA), than by is very name. BTA was initially approved for cosmetic and 
therapeutic use.(2, 19) 
BTX is a protease that causes temporary desensitization of the skeletal muscles; 
it’s a neurotoxin with high affinity for cholinergic synapses, blocks the release of 
acetylcholine by nerve endings without interfering with neuronal conduction of 
electrical signals or synthesis and storage of acetylcholine. It has been proven that BTX 
can selectively weaken painful muscles, interrupting the spasm-pain cycle. Several 
studies have demonstrated the efficacy and safety of BTA in the treatment of migraines, 
myofascial pain, massoteric hypertrophy and facial asymmetry of muscular origin, 
parafunctional habits, sialorrhea, temporomandibular disorders (TMDs), gingival smile, 
among others.(7, 9, 13, 15, 19-24) 
 
 
Massoteric hypertrophy and facial asymmetry of muscular origin 
 
The massometric hypertrophy is the excessive development of the masseter 
muscle, uni or bilateral, being of idiopathic character. It leads to aesthetic facial 
compromise interfering with the patient's self-esteem and affects, usually, young 
people. In some cases, besides the aesthetic, there is functional incapacity of this muscle 
due to occlusal disharmony and orofacial pains that are difficult to solve.(3, 25-27) 
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Clinically it is observed the increase of volume of the masseter muscle, uni or 
bilaterally, of easy delimitation, smooth consistency to palpation and generally 
asymptomatic. Although most often the main complaint is aesthetic, it may be present 
tenderness to palpation, functional disability due to pain and complaint of occlusal 
disharmony.(3, 26-28) 
Surgical treatment involves interventions that are performed, only in the 
compromised muscles, only in the bone structure of the mandibular angle or the 
association of both procedures.  The main treatments currently known are occlusal 
adjustments, use of spasmolytic medications, tranquilizers and antidepressants.(3, 27, 28) 
 When injected into a muscle, BT causes interference with the neurotransmitter 
mechanism producing selective paralysis and successive atrophy of the muscle which is 
a common treatment for cosmetic reduction of the masseters as well as for conditions 
involving muscle spasm and pain.(27-29) 
Currently, facial growth has been influenced by the use of botulinum toxin type 
A that has been used to induce muscular hypofunction. Because it is noninvasive and 
reversible, it represents, for the clinician, a safe and effective alternative for the 
treatment of masseter muscle hypertrophy, when conservative treatments have been 
unsuccessful.(3, 18, 25, 28, 30) 
According to several authors, there was satisfactory regression of muscular 
hypertrophy and a significant improvement of facial asymmetry. The results appeared 
acceptable aesthetic and short-term effect, which indicates that BTA is effective in the 
treatment of facial asymmetries.(3, 26, 28, 30) 
However, to several authors, using TB in a long term the mechanical properties 
of the temporomandibular joint may be compromised and even may occur bone loss.(18, 
23, 28, 29) 
 
Chronic Pain: Myofascial Pain, Migraine 
 
Orofacial pain may be caused by a massive assortment of diseases. There are a 
set of conditions that belong to the group of chronic pain such as myofascial pain, 
migraine and atypical odontalgia.(31, 32) 
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Myofascial pain syndrome (MPS) is defined as a musculoskeletal disorder caused 
mainly by the active point of the trigger (trigger point) exhibiting sensory, motor and 
autonomic symptoms. Sensory disorder that apparent dysesthesia, hyperalgesia, and 
referred pain. It’s usually a result and sometimes a product of, both emotional 
influences and physical factors.  Fatigue, depression, anger, sleep disturbance, and 
altered mental function are commonly experience by patients with MPS, and an 
interdisciplinary approach to address the many dimensions of the pain experience is 
needed.(15, 30, 33-35) 
Migraine is a chronic neurological/neurovascular  disturb associated with sterile 
inflammation and vasodilatation, which activate the trigeminal afferents on the vessel 
wall  causing pain .(15, 30) 
Atypical odontalgia (AO) is one of the few sources of facial pain. It is a subform 
of persistent idiopathic facial pain, and is defined as a continuous toothache in which a 
thorough examination reveals no dental pathology. AO is believed to be a neuropathic 
condition, given that some cases are preceded by dental procedures. Different topical 
and systemic medications have been used for the treatment of AO, but their effect is 
often deficient.(31, 32, 36) 
BTX may reduce muscle contractility by preventing ACh release from the 
presynaptic terminal and decrease parasympathetic outflow, leading to analgesia. 
Because of that it may be a therapeutic option.(30, 33, 37) 
 
 
Parafunctional Habits and Implants 
 
The parafunctional habit of controversial origin, ranging from psychological 
disturbances, central nervous system disorders, malocclusion to genetic factors is called 
bruxism. It is characterized by the grinding of teeth, being nocturnal or diurnal. The 
tooth wear, muscle or temporomandibular pain and, in more advanced cases, postural 
and / or skeletal dysfunction and degenerative temporomandibular joint arthritis are 
the complications of this habit.(4, 19, 38-43) 
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In the planning of dental implants, bruxism becomes a highly relevant factor and 
should be minimized so that there is no occlusal overload and, consequently, no loss of 
the implant. The failure of most implants is because to occlusal overload and not due to 
osseointegration problems or peri-implant diseases. It is due to the absence of the 
periodontal ligament the low resistance of the implant to this overload, which greatly 
limits the proprioception and hampers the distribution of tension in the peri-implant. 
Thus, it is necessary and relevant to verify signs of bruxism during the planning of clinical 
cases, and in these situations, it is necessary to resort to methods that can minimize it. 
Sleep bruxism leads to an increase in occlusal and lateral forces, both in magnitude and 
duration, and is therefore related as a considerable risk factor for dental implants, and 
the prognosis for prosthetic treatment with implants in patients who this condition is 
always doubtful.(4, 37, 41-45) 
About the use of botulinum toxin for the treatment of bruxism much has been 
said about. Botox  reduces  the  muscle  activity  by  blocking  overactive nerve impulses  
that  trigger  excessive  muscular  contractions by selectively preventing the release of 
the neurotransmitter acetylcholine(ACh) at the neuromuscular junction. Also in the 
planning of dental implants, is very effective the prophylactic use of botox injections in 
achieving true bone to implant connection.(4, 27, 37, 45) 
BT may be used as a treatment option in patients with bruxism, since the 
treatments available for this parafunctional habit are not completely effective. It works 
by reducing peripheral muscle activity because it is a potent and specific muscle 
relaxant. Botox reduces pain by promoting relaxation of masticatory muscles and 
allowing proper mandibular function. Side effects are rare and, even if they exist, are 
transient, causing no major problems for patients.(2, 4, 7, 30, 37-39, 42, 43, 46) 
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Sialorrhea 
 
The spillage of saliva due to either the excessive production of saliva (primary 
sialorrhea) or decreased frequency of swallowing (secondary sialorrhea) in which there 
is accumulation of saliva in the oral cavity with continuous need of elimination, causing 
difficulties in speech, social embarrassment, oral infections, halitosis and dehydration 
and associated with several neurological disordersis what can be considered as the 
definition of sialorrhea.(46-49) 
  In patients with sialorrhea, the application of BTX-A in the salivary glands was 
advantageous, conceding the reduction of saliva accumulation in the oral cavity and 
pharyngeal recess and consequent onset of speech-language therapy. During the 
botulinum toxin effect period one of the main aspects observed was the improvement 
of swallowing function. One only application of the medicine was enough for patients 
to present conditions for speech therapy and reintroduction of oral feeding There are a 
improvement of mobility and strength of oropharyngeal structures, a reduction of saliva 
accumulation and improvement of swallowing, a reintroduction of food by mouth and 
a removal of the tracheostomy cannula and occlusion of the tracheostoma after 
application of BTA associated with speech therapy. BT acts on the cholinergic nerve 
endings, causing proteolysis of SNAP-25, chemical denervation, and loss of neuronal 
activity.(19, 30, 48) 
The use of botulinum toxin in salivary glands in vivo was reported primary in 
patients with amyotrophic lateral sclerosis (ALS) to block the action on cholinergic 
autonomic fibers. Saliva remains the same in the oral cavity and oropharynx and/or 
extraoral leak of saliva indicate neurogenic failure in coordination of tongue, palate and 
facial muscles that act in the first stage of swallowing, in many neurological diseases.(19, 
47, 50) 
Among the treatment option, it is used anti-Parkinson drugs, drugs with anti-
cholinergic effects, radiotherapy in salivary glands, surgical treatment of salivary ducts 
or glands and more, recently, application of botulinum toxin type A in salivary glands. 
Botox may be a better alternative in the case of patients who are intolerant to the 
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adverse effects of the medication used or who present very advanced and severe clinical 
situations of the neurological disease that prevent the surgical treatment. .(48, 50) 
Recently, the percutaneous injection of botulinum neurotoxin type A into 
salivary glands has been shown to be effective in abolishing excessive sialorrhoea 
associated with several neurological disorders. Since it is able to improve quality of life, 
may be a valid treatment option in patients with sialorrhea in a medium-term 
solution.(47, 48, 50) 
 
 
Gingival smile and lip asymmetry 
 
The gingival smile, also called the doggy or horse smile, is a very common and 
unsightly condition defined as an individual displaying a smile of more than 3 mm of 
gingival tissue, with a greater incidence in females. In Even over, a person's smile can 
express a sense of joy, happiness, pleasure, good mood, success and sensuality, that is, 
it is a form of communication, socialization and attraction.(8, 9, 51-57) 
With the increase of aesthetic requirement of the patients, currently, a 
stereotyped smile is proposed. The harmony of the smile is determined by the gingival 
tissue and not only by the shape, position and color of the teeth. The so-called gingival 
smile is characterizes by the excessive exposure of the periodontium. Firstly, a correct 
diagnosis should be established by properly classifying the gingival level, respecting 
variables such as gender, age and periodontal health. After the diagnosis has been 
made, the etiology must be determined. So a gingival smile is not exclusive to a short 
lip. This is attributable to several factors, including hyperfunction of the perioral muscles 
(orbicularis oris, zygomaticus major and minor, depressor septi nasi, levator labii 
superioris alaeque nasi/anguli oris), lip length, clinical crown length, skeletal problems 
caused by maxillary excess, altered passive eruption of teeth and dentoalveolar 
extrusion, resulting in gingival problems. Many authors have proposed surgical 
approaches, but these procedures are associated with morbidity and high cost and are 
time-consuming. (8, 9, 19, 51-58) 
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Diagnosing the gingival smile, BTX serves as a substitute for surgical treatment, 
being a modality of minimally invasive correction treatment.(9, 19, 21, 57) 
Despite being a simple and safe procedure, the injection of botulinum toxin may 
be associated with some adverse effects such as, edema, pain at the site of injection, 
dysphonia, bruising, smile asymmetry, infection, dysphagia and ptosis or upper lip 
stretching. The dentist should be aware of the posology, the accuracy of the technique 
and the location of the puncture.(8, 55) 
The gingival smile has implications on the patient's self-esteem and social life. In 
fact, this affects the esthetic and the psychological status as it usually decreases the self-
confidence leading to hidden or controlling the smile.(8, 9, 51, 55, 58) 
For successful treatment are crucial the correct diagnosis of the cause and the 
proper selection of the technique for correcting the gummy smile. In addition, extensive 
surgical procedures can be replace by botulinum Toxin. BTX acts by cleaving SNAP-25, 
which blocks ACh release from motor neurons and enables repolarization of the 
postsynaptic terminal, resulting in partial chemodenervation and blockade of muscular 
contraction. It is considered as one of the minimally invasive, easy, quick and affordable 
therapy. However, for Walsh (2012), botox may not be the best form of treatment, 
although it is the most desired option for the patient because it is better known and due 
to its immediate effect. The author also reports that dental surgeons could not 
administer botox for three reasons: for the pharmacological principles of botox are 
addressed in dentistry at a very basic level; because the dentist does not have enough 
training on the detailed anatomy of the face for the safe application of botox; and for 
the use of botox to be more used at the cosmetic level and not so much at the dental 
level. With a strong understanding of actions and limitations and careful selection of 
cases, BTX may represent a strong treatment option for patients with a gingival smile. 
Thus, the application of BT requires a great dominance over the anatomy and an 
abundant learning about its application. (8, 9, 30, 51, 52, 55, 56, 58, 59) 
It is the duty of all professionals to keep up-to-date on the technical and scientific 
knowledge required for professional practice.(9, 56, 59) 
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Facial Dystonias  
 
A normal facial function is of a colossal significance to the physical, psychological, 
emotional and social well-being of a person.(60) 
In recent years, in the more developed neurological centers, the use of 
botulinum toxin type A has become a relatively growing practice, especially indicated in 
the treatment of movement disorders, such as: focal dystonias (blepharospasm), 
hemifacial spasm (“involuntary tonic or clonic contractions, paroxysmal, limited to the 
muscles of one side of the face, innervated by the facial nerve. It usually begins with 
intermittent eyelid tremors in one eyelid. In months or years, there is progression and 
involves adjacent areas innervated by the facial, compromising all muscles on the side 
of the affected face”), craniofacial dystonias (“a group of diseases characterized by 
involuntary movements of the face, tongue, palate, pharynx, vocal chords and neck”), 
facial paralysis (“the inability to express emotions and perform functional movements. 
This leads to a decrease in quality of life to cause functional and aesthetic problems that 
are emphasized to speak and smile, causing psychological effects such as loss of 
confidence to perform daily activities in public”) among others.(22, 60, 61) 
The diagnosis of these dystonias is basically clinical. The diagnosis is made 
retrospectively, with the progression of symptoms and the interference of daily 
activities and the clinical picture is instated insidiously. These symptoms are 
exacerbated by environmental conditions such as light, brightness, optokinetic stimulus, 
stress and interpersonal relations.(61, 62) 
BTX acts at the neuromuscular junction by inhibiting the release of ACh and 
preventing muscle contraction and that is why this toxin has proven to be a safe and 
highly effective method for the treatment of facial dystonias.(17, 22, 30, 61, 63, 64) 
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Cosmetic Usage 
 
The botulinum type A toxin, currently, plays an important role in aesthetic-
medical treatments of the face. It has been used, since first described by Carruthers, for 
the treatment of facial wrinkles. (19, 52, 65, 66) 
Its use has extended especially in the treatment of external lines of the can thus 
(crow’s feet), forehead wrinkles, for modifying the position of the eyebrows in the 
glabella area, as well for horizontal neck lines. In the middle and lower third of the face 
it is less used. It has been used to create the effect of a fuller top lip, for the treatment 
of peribuccal lines or to modify the nasolabial angle, among other applications. The 
dentist need to be aware of their safe action on the various anatomical structures 
involved. (19, 37, 65-69) 
 
 
How to use 
 
Partial chemical denervation of the muscle is produced by Botox, resulting in 
localized reduction in muscle activity. It can be used as an adjunct to oral medication or 
as a single therapy. It is unknown the lethal dose of Botox in humans although it has 
been estimated at around 3000 U. The usual maximum recommended dose for dental 
applications in an injection session is about 80-100 U. It would be necessary injected 30 
bottles of Botox before a potentially lethal result. A fatal overdose is almost impossible 
because the disproportion between the clinical dose and the lethal dose. The skin should 
be cleaned with chlorhexidine swab / alcohol / betadine before injecting Botox into 
muscle and / or joint and / or skin. A small electric recorder or EMG machine can be used 
to determine the site to be injected into the muscle, helping to correctly locate the area 
of the muscle to be injected. Can also be used for deeper joints or muscles Ultrasound 
guided injections. Botox is injected using 1 ml of tuberculin syringe and 0.30 gauge half 
inch needle. Injections of a small amount of this toxin into a muscle produces atrophy 
and weakness in 1-20 days and recovers within 2-4 months as new terminal axons 
germinate and restore the transmission. To minimize the risk of antibody formation to 
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the protein the injections are spaced for a minimum of 3 months, which would prevent 
Botox from functioning in the subsequent time. The injected muscle is paralyzes or 
weakens by Botox, but leaves the other muscles the same. Injections block extra muscle 
contractions but leave enough force for normal use.(27, 37) 
 
Side effects and contraindications to the use of botulinum toxin 
 
The side effects of botulinum toxin on the body are related to the frequency and 
amount of the dose. These are dizziness, anxiety, fever, hypotension, nausea, headache, 
facial pain, pruritus, dry mouth and eyes, speech difficulties, edema of face, dysphagia, 
allergic reaction like rash, flu-like symptoms, urticaria, sweating, itching, chills, paralysis 
respiratory infection, loss of strength, among others.(26, 27, 30, 66) 
The use of Botox is contraindicated during an infection or inflammation of the 
area where the toxin injections are planned, in primary muscular disorders (muscular 
dystrophy, neuromyopathy, congenital myopathies, myotonic disorders, mitochondrial 
myopathy and unspecified or other primary muscle disorders), in women during 
pregnancy and lactation, in patients with musculoskeletal conduction disorders, in 
patients with known hypersensitivity to any component of the drug, in patients being 
treated with succinylcholine, pancuronium, aminoglycoside antibiotics, tubocurarine, 
ciclosporin, galamine, hydroxychloroquine, D-penicillamine or chloroquine. The risk of 
transmission of a viral infection cannot be eliminated with certainty due to the 
hemagglutinin content. The availability of anti-allergic medicinal products should be 
ensured prior to the application of the medicinal product.(8, 9, 16, 27, 28, 30, 66, 70) 
So, summing up, this toxin proved to be a safe, effective, minimally invasive and 
reversible alternative in the treatment of many conditions.(3, 26, 28, 30) 
However, more studies are needed to reach a definitive conclusion about 
efficacy and safety in cases of chronic pain, parafunctional habits and implants. With 
regard to sialorrhoea it is necessary to evaluate the maximum doses, the location of the 
most effective and safe injection points and the definition of the number of infiltrations 
required by the TBA. Lastly, in facial dystonias it's needed confirm the hypothesis of the 
drug tolerance effect, which should only be administered by professionals familiar with 
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the pharmacological properties of the drug and with full knowledge of the anatomical 
characteristics of the region in which the drug should be injected).(2, 4, 15, 30, 31, 35, 37, 38, 47, 
48, 50, 61, 63, 64, 66) 
Thus, it is require a thorough learning and a greater dominance of the dynamic 
anatomy with the application of BT. When administered in the appropriate doses by an 
experienced clinical specialist is a safe therapy option. However, the largest counterpart 
is that the effect of BT is reversed by motor endplate regeneration and generally leads 
to the re-establishment of symptoms. The treatment has to be repeated at intervals of 
two to three months once the symptoms re-appear.(8, 9, 27, 30, 51, 52, 55, 56, 58) 
 
Legislation 
 
On BTX applications in dentistry, it is important that the Dentist is aware of its 
possible risks, as well as the correct indications, avoiding possible damages. 
There are specific guidelines for each indication, as BTX should only be 
administered by physicians with appropriate qualifications and experience in the 
treatment and use of the necessary equipment. For all indications, the ideal dose or the 
number of generally suitable injection sites for muscle have not yet been established. In 
these cases, individual treatment regimens should therefore be established by the 
physician. The optimal dose should be determined by adjusting the individual dose, but 
the maximum recommended dose should not be exceeded. (INFARMED, 2014) 
In individuals with known hypersensitivity to Botulinum Toxin type A or in the 
presence of infection at the proposed injection site, the application is contraindicated. 
The recommended doses and dosing frequencies for BTX should not be exceeded 
because of the potential for overdose, excessive muscle weakness, diffusion of the toxin 
to distant sites and formation of neutralizing antibodies. The starting dose for patients 
who have not been previously treated should be the lowest recommended dose for the 
particular indication. Prescribers and patients should be aware that even if previous 
injections have been well tolerated adverse effects may occur. Therefore, precautions 
should be taken in each administration. (INFARMED, 2014) 
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CONCLUSION 
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In patients with head and face disorders of different etiologies, BT is a useful and 
minimally invasive treatment option in the treatment of challenging clinical problems, 
improving the quality of life. It is clear that the potential use of BT in the dental 
profession can be of great value, although broader confirmation of its use is required in 
multiple dental applications. 
The fundamental limitations of botulinum toxin are due to the average duration 
of its therapeutic effect which requires the repetition of the treatment every three 
months throughout the life of the patient, which is not only uncomfortable, but also 
favors the emergence of resistances. 
In future the effects of these treatments are expected to be longer lasting. 
In conclusion, Botox is one of the most promising and exciting new additions to 
the dentist's arsenal for treating numerous conditions. Although further studies on 
botulinum toxin are needed in the future, this has proved to be a great ally of the dental 
surgeon in the therapeutic treatment of several symptomatic alterations. 
Finally, there was also an increase in the training of dentists for its use, but 
legislation in Portugal is still lacking for its correct application. 
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ANEXO 1- DECLARAÇÃO DE AUTORIA 
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ANEXO 2- PARECER DA ORIENTADORA 
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